{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:02Z","timestamp":1790679182924,"version":"4.1.0"},"reference-count":15,"publisher":"Wiley","issue":"s447","license":[{"start":{"date-parts":[[2007,1,2]],"date-time":"2007-01-02T00:00:00Z","timestamp":1167696000000},"content-version":"vor","delay-in-days":672,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Aim:<\/jats:italic>\n                    Mutations of the gene (\n                    <jats:italic>GLA<\/jats:italic>\n                    ) encoding \u03b1\u2010galactosidase A are implicated in Fabry disease, a progressive, X\u2010chromosomal inherited lysosomal storage disorder. FOS \u2013 the Fabry Outcome Survey \u2013 was established as a long\u2010term surveillance study to describe the natural course of Fabry disease and its response to enzyme replacement therapy in a large cohort of European patients. Clinical phenotype, age of onset and course of Fabry disease are very variable, even within the same family, which makes it difficult to define a genotype\u2013phenotype relationship by analysing individual patients. The FOS database contains detailed medical information on a large cohort of patients and thus has the potential to provide important information to address this question.\n                    <jats:italic>Methods:<\/jats:italic>\n                    At the time of analysis, information on 545 patients belonging to 157 families from nine European countries had been entered into the FOS database. A\n                    <jats:italic>GLA<\/jats:italic>\n                    mutation has been reported in 365 individuals (65% and 68% of all males and females, respectively) in FOS. These data were used to analyse the relationship between genotype and phenotype in Fabry disease.\n                    <jats:italic>Results:<\/jats:italic>\n                    A highly significant positive correlation was found between the age at entry into FOS and the FOS Severity Index in male patients with\n                    <jats:italic>GLA<\/jats:italic>\n                    missense mutations (\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.001) as well as in those carrying other types of mutations (\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.001). A positive correlation was also found between the age at entry into FOS and the number of affected organs in male patients with missense mutations, irrespective of whether the change in the amino acid side chain predicted in the \u03b1\u2010galactosidase A protein was classified as a conservative or non\u2010conservative change.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The data presented here suggest that there is a correlation between genotype and clinical severity.\n                  <\/jats:p>","DOI":"10.1111\/j.1651-2227.2005.tb02119.x","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T20:00:42Z","timestamp":1281124842000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey"],"prefix":"10.1111","volume":"94","author":[{"given":"E","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/rwgn.2001.0443"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.769"},{"key":"e_1_2_6_5_2","article-title":"Thirty\u2010four novel mutations of the GALA gene in 121 patients with Fabry disease","author":"Sch\u00e4fer E","journal-title":"Hum Mutat"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2001.600107.x"},{"key":"e_1_2_6_7_2","first-page":"227","article-title":"Fabry disease: twenty\u2010two novel mutations in the alpha\u2010galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes","volume":"48","author":"Ashton\u2010Prolla P","year":"2000","journal-title":"J Investig Med"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/339431"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402156"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401671"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00219.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.01.035"},{"key":"e_1_2_6_15_2","first-page":"1186","article-title":"Nature and frequency of mutations in the alpha\u2010galactosidase A gene that cause Fabry disease","volume":"53","author":"Eng CM","year":"1993","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2003.00077.x"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2005.tb02119.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2005.tb02119.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:05:47Z","timestamp":1695809147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2005.tb02119.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":15,"journal-issue":{"issue":"s447","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1651-2227.2005.tb02119.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2005.tb02119.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2007-01-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}